|
Volumn 16, Issue SUPPL. B, 2003, Pages 9-13
|
Remission of depression and the Texas Medication Algorithm Project
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ALGORITHM;
BIPOLAR DISORDER;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG COST;
FOLLOW UP;
HEALTH CARE COST;
HUMAN;
MAJOR DEPRESSION;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PSYCHOPHARMACOTHERAPY;
PSYCHOTHERAPY;
QUALITY OF LIFE;
REMISSION;
REVIEW;
SCHIZOPHRENIA;
SIDE EFFECT;
SLOW DRUG RELEASE;
TREATMENT OUTCOME;
UNITED STATES;
ADULT;
ARTICLE;
COST BENEFIT ANALYSIS;
DECISION SUPPORT SYSTEM;
MULTICENTER STUDY;
ADULT;
ALGORITHMS;
ANTIDEPRESSIVE AGENTS;
COST-BENEFIT ANALYSIS;
DECISION SUPPORT SYSTEMS, CLINICAL;
DEPRESSIVE DISORDER, MAJOR;
HUMANS;
PRACTICE GUIDELINES;
REMISSION INDUCTION;
TEXAS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 0037289768
PISSN: 10965645
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (5)
|
References (7)
|